digital health startups weight loss glp-1 25 Transforming The Weight-Loss Landscape GLP-1 Business Report for Healthtech

3): Novo Nordisk, the patent holder and manufacturer of the GLP-1 products Ozempic, Rybelsus and Wegovy (semaglutide) has spent 41% more on shareholder enrichment (buybacks and dividends) as it has on R&D in the past five years

Its also been found to improve our gut microbiome and lower our body mass index

Research published in the journal Engl J Med , found that what you're eating, as well as how much, is important for both fat loss and general health

Ros body program combines GLP-1 medication with 1:1 personal coaching and 12 months of curriculum and support to help lose weight and keep it off

All of those changes will need to be part of the equation, whether medication is used or not. And if youre putting in the work and the scale is not changing, Talk to your doctor or see an obesity medicine specialist to see what is going on, Cleek said

Analysts project that within five years, annual spending on GLP-1 obesity drugs could exceed $100 billion